NCT07031830Recruiting
APA (Adapted Physical Activity) for Patients With Advanced Melanoma
APA (Adapted Physical Activity) for Patients With Advanced Melanoma APA (Adapted Physical Activity) for Patients With Advanced Melanoma Undergoing Treatment: Evaluation of a Personalized Program at the Hospital
Source: ClinicalTrials.gov · Last updated 22 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
APA (adapted physical activity) for patients with advanced melanoma APA (adapted physical activity) for patients with advanced melanoma undergoing treatment: evaluation of a personalized program at the hospital Melanoma is a malignant tumor developed from melanocytes. It accounts for approximately 4% of all incident cancers and 1.2% of cancer deaths, regardless of sex. Since 2011, the advent of new therapies (targeted therapies and immunotherapies) has revolutionized the management of advanced-stage melanoma (unresectable stage III or stage IV). These treatments have led to a significant improvement in the prognosis of metastatic melanoma, with a 5-year overall survival rate of 34% for targeted therapies, 44% for monotherapy with immunotherapy, and 52% for the combination of nivolumab + ipilimumab. Due to the improvement in survival rates, advanced melanoma has become a chronic disease affecting all ages. It is therefore essential to maintain the quality of life for these patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 4 Jun 2025
- Start date
- 18 Nov 2024
- Primary completion date
- 18 Nov 2028
- Lead sponsor
- University Hospital, Rouen
- Diseases
- Melanoma
- NCT number
- NCT07031830
What you commit to
- Study type: Observational
- Planned participants: 50
- From 18 Nov 2024 to the primary completion date, 18 Nov 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Condition making 6-month follow-up impossible
Other
- Minor patient
- Melanoma not requiring systemic treatment
- Protected incapacitated persons (judicial protection, guardianship, curatorship, deprivation of liberty)
Who the study is looking for
- Male or female patient aged 18 or older
- Advanced melanoma treated adjuvantly or curatively with immunotherapy or targeted therapy
- Patient who has read and understood the information letter and does not object to participating in the study
- Member of or beneficiary of a social security scheme
- Patients who have agreed to participate in the adapted sports module
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Rouen Hospital Coordinator of this site? Confirm its status | Rouen | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.